[Effects of prolonged administration of thyrocalcitonin in human senile osteoporosis. Clinical, histological and radiographic study].
D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001706:Biopsy; D002116:Calcitonin / Q000008:administration & dosage / Q000494:pharmacology*; D002118:Calcium / Q000097:blood / Q000652:urine; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006882:Hydroxyapatites / Q000378:metabolism*; D007085:Ilium / Q000473:pathology; D007273:Injections, Intramuscular; D008852:Microradiography; D010011:Osteocytes / Q000187:drug effects*; D010024:Osteoporosis / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D010758:Phosphorus / Q000097:blood / Q000652:urine; D010783:Photometry
D006882:Hydroxyapatites; D010758:Phosphorus; D002116:Calcitonin; D000469:Alkaline Phosphatase; D002118:Calcium
Effets de l'administration prolongée de thyrocalcitonine dans l'ostéoporose sénile humaine. Etude clinique, histologique et microradiographique.